DELAYED TREATMENT WITH AMPA BUT NOT NMDA GLUTAMATE ANTAGONISTS REDUCES NEOCORTICAL INFARCTION

DELAYED TREATMENT WITH AMPA BUT NOT NMDA GLUTAMATE ANTAGONISTS REDUCES NEOCORTICAL INFARCTION

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Xue, D, Huang, Z, Smith, K, Lesiuk, H, Buchan, A
Μορφή:	Journal article
Έκδοση:	1992

Παρόμοια τεκμήρια

Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
ανά: Xue, D, κ.ά.
Έκδοση: (1994)

POSTISCHEMIC TREATMENT WITH AMPA, BUT NOT NMDA, ANTAGONISTS PREVENTS CA1 NEURONAL INJURY
ανά: Li, H, κ.ά.
Έκδοση: (1992)

AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
ανά: Buchan, A, κ.ά.
Έκδοση: (1993)

Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia.
ανά: Buchan, A, κ.ά.
Έκδοση: (1991)

Ionotropic Glutamate Receptors in Epilepsy: A Review Focusing on AMPA and NMDA Receptors
ανά: Takahisa Hanada
Έκδοση: (2020-03-01)

NMDA antagonists: their role in neuroprotection.
ανά: Small, D, κ.ά.
Έκδοση: (1997)

NMDA antagonists: their role in neuroprotection.
ανά: Small, D, κ.ά.
Έκδοση: (1997)

MK-801 REDUCES THE VOLUME OF NEOCORTICAL INFARCTION BUT ALSO INCREASES REGIONAL CEREBRAL BLOOD-FLOW
ανά: Buchan, A, κ.ά.
Έκδοση: (1990)

The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
ανά: Buchan, A, κ.ά.
Έκδοση: (1992)

Do NMDA antagonists prevent neuronal injury? No.
ανά: Buchan, A
Έκδοση: (1992)

The rise and fall of NMDA antagonists for ischemic stroke.
ανά: Hoyte, L, κ.ά.
Έκδοση: (2004)

AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.
ανά: Falko Lange, κ.ά.
Έκδοση: (2019-01-01)

Аlterationdegree of NMDA and AMPA receptors of glutamate in the pathogenesis of the disease and technological peculiarities of surgical treatment of the hemispheric glioma-swith the epileptic syndrome
ανά: V. N. Ochkolyas, κ.ά.
Έκδοση: (2014-06-01)

Facilitation of neocortical presynaptic terminal development by NMDA receptor activation
ανά: Sceniak Michael P, κ.ά.
Έκδοση: (2012-02-01)

The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi.
ανά: Higo Fernando Santos Souza, κ.ά.
Έκδοση: (2019-09-01)

Modulation of NMDA and AMPA/kainate receptors by tocotrienol-rich fraction and α-tocopherol in glutamate- induced injury of primary astrocytes
ανά: Abedi, Zahra
Έκδοση: (2017)

The modulation of NMDA and AMPA/kainate receptors by tocotrienol-rich fraction and A-tocopherol in glutamate-induced injury of primary astrocytes
ανά: Abedi, Zahra, κ.ά.
Έκδοση: (2017)

The Modulation of NMDA and AMPA/Kainate Receptors by Tocotrienol-Rich Fraction and Α-Tocopherol in Glutamate-Induced Injury of Primary Astrocytes
ανά: Zahra Abedi, κ.ά.
Έκδοση: (2017-12-01)

U74006F REDUCES NEOCORTICAL INFARCTION BUT DOES NOT ATTENUATE SELECTIVE HIPPOCAMPAL CA1 NECROSIS
ανά: Dong, X, κ.ά.
Έκδοση: (1990)

NMDA Receptor Antagonists for Treatment of Depression
ανά: Zeynep Ates-Alagoz, κ.ά.
Έκδοση: (2013-04-01)

Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?
ανά: Buchan, A
Έκδοση: (1990)

Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia.
ανά: Hicks, C, κ.ά.
Έκδοση: (1999)

How microelectrode array-based chick forebrain neuron biosensors respond to glutamate NMDA receptor antagonist AP5 and GABAA receptor antagonist musimol
ανά: Serena Y. Kuang, κ.ά.
Έκδοση: (2016-09-01)

CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo.
ανά: Menniti, F, κ.ά.
Έκδοση: (2003)

Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury.
ανά: Li, H, κ.ά.
Έκδοση: (1993)

NMDA receptor antagonists in the treatment of neurological diseases
ανά: I. S. Preobrazhenskaya
Έκδοση: (2020-10-01)

Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation
ανά: Daniela Bonini, κ.ά.
Έκδοση: (2016-01-01)

The earliest neuronal responses to hypoxia in the neocortical circuit are glutamate-dependent
ανά: Omer Revah, κ.ά.
Έκδοση: (2016-11-01)

Immediate or delayed mild hypothermia prevents focal cerebral infarction.
ανά: Xue, D, κ.ά.
Έκδοση: (1992)

Neuroprotection, excitotoxicicity and nmda antagonists
ανά: RUBENS JOSÉ GAGLIARDI
Έκδοση: (2000-06-01)

HYPOTHERMIA BUT NOT NMDA RECEPTOR ANTAGONIST MK-801 ATTENUATES NEURON DAMAGE - ARE THE RESULTS CONCLUSIVE - REPLY
ανά: Buchan, A, κ.ά.
Έκδοση: (1992)

NEUROPROTECTIVE PROFILE OF FPL-15896AR, A NOVEL UNCOMPETITIVE NMDA ANTAGONIST
ανά: Murray, R, κ.ά.
Έκδοση: (1995)

Differential modulation of NMDA and AMPA receptors by cellular prion protein and copper ions
ανά: Sun Huang, κ.ά.
Έκδοση: (2018-10-01)

Differential expression of AMPA subunits induced by NMDA intrahippocampal injection in rats
ανά: Helene Aparecida Fachim, κ.ά.
Έκδοση: (2016-02-01)

Mechanism of partial agonism in AMPA-type glutamate receptors
ανά: Hector Salazar, κ.ά.
Έκδοση: (2017-02-01)

Memantine, an antagonist of the NMDA glutamate receptor, affects cell proliferation, differentiation and the intracellular cycle and induces apoptosis in Trypanosoma cruzi.
ανά: Flávia Silva Damasceno, κ.ά.
Έκδοση: (2014-02-01)

A new model of temporary focal neocortical ischemia in the rat.
ανά: Buchan, A, κ.ά.
Έκδοση: (1992)

NMDA receptor antagonists in the treatment of patients with vascular cognitive imprairments
ανά: I.S. Preobrazhenskaya
Έκδοση: (2014-10-01)

NMDA and AMPA Receptors at Synapses: Novel Targets for Tau and α-Synuclein Proteinopathies
ανά: Maria Italia, κ.ά.
Έκδοση: (2022-06-01)

Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice
ανά: Corsi Massimiliano M, κ.ά.
Έκδοση: (2006-10-01)